Cognition Therapeutics Inc (CGTX)

Apr 13, 2026

CGTX: Phase III trials for zervimesine in DLB psychosis and Alzheimer's are advancing with strong safety and efficacy data - TradingView — Track All Markets

Apr 13, 2026

Apr 13, 2026

Cognition Therapeutics Targets Faster DLB Psychosis Path as Zervimesine Nears Late-Stage Plans - Yahoo Finance

Apr 13, 2026

Apr 13, 2026

Update Report: Can Cognition Therapeutics Inc disrupt its industryQuarterly Trade Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Insider Trends: Whats the fair value of Cognition Therapeutics Inc stockSell Signal & Real-Time Market Sentiment Reports - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Insider Sell: Can Cognition Therapeutics Inc disrupt its industryPortfolio Gains Summary & Daily Stock Momentum Reports - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Big Picture: Whats the fair value of Cognition Therapeutics Inc stockQuarterly Trade Report & Real-Time Chart Pattern Alerts - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Lewy Body Dementia Market: Accelerating Growth and Pipeline Impact by 2034– DelveInsight | Cognition Therapeutics, KeifeRx, Eisai, EIP Pharma, Sun Pharma, Axovant Sciences Ltd., Cognition Therapeutics - Barchart.com

Apr 09, 2026

Apr 09, 2026

Lewy Body Dementia Market: Accelerating Growth and Pipeline - openPR.com

Apr 09, 2026

Apr 07, 2026

Cognition Therapeutics to Present at Needham Virtual Healthcare Conference - Bitget

Apr 07, 2026

Apr 07, 2026

Cognition Therapeutics, Inc. CEO Lisa Ricciardi to Present at 25th Annual Needham Virtual Healthcare Conference - Quiver Quantitative

Apr 07, 2026

Apr 07, 2026

CEO to give Alzheimer's, Lewy body drug update on April 13 - Stock Titan

Apr 07, 2026

Apr 06, 2026

Fed Meeting: What is the PEG ratio of Cognition Therapeutics Inc2026 Outlook & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 03, 2026

CGTX Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 03, 2026

Apr 02, 2026

CGTX Should I Buy - Intellectia AI

Apr 02, 2026

Apr 01, 2026

Cognition Therapeutics CEO Issues Letter to Shareholders - The Manila Times

Apr 01, 2026

Apr 01, 2026

Cognition Therapeutics plans late-stage trial for dementia drug By Investing.com - Investing.com Australia

Apr 01, 2026

Mar 31, 2026

Cognition Therapeutics plans late-stage trial for dementia drug - Investing.com

Mar 31, 2026

Mar 30, 2026

Cognition Plunges 21.8% on Intraday Carnage — What’s Triggering This Sharp Drop? - Bitget

Mar 30, 2026

Mar 30, 2026

Q1 Earnings Forecast for CGTX Issued By HC Wainwright - MarketBeat

Mar 30, 2026

Mar 28, 2026

Here's Why We're Watching Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Situation - Sahm

Mar 28, 2026

Mar 27, 2026

Cognition Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets

Mar 27, 2026

Mar 27, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 27, 2026

Mar 27, 2026

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 27, 2026

Mar 27, 2026

Cognition Therapeutics (NASDAQ:CGTX) Receives Buy Rating from Chardan Capital - MarketBeat

Mar 27, 2026

Mar 27, 2026

Cognition Therapeutics posts narrower 2025 loss, eyes DLB trial By Investing.com - Investing.com South Africa

Mar 27, 2026

Mar 26, 2026

Cognition Therapeutics Reports 2025 Financial Results and Advances Zervimesine for DLB Psychosis and Alzheimer’s Clinical Trials - Minichart

Mar 26, 2026

Mar 26, 2026

Cognition Therapeutics Inc (CGTX) Q4 2025 Earnings Call Highlights: Promising Developments in ... By GuruFocus - Investing.com Canada

Mar 26, 2026

Mar 26, 2026

Cognition Therapeutics Advances Zervimesine (CT1812) for Alzheimer’s and Dementia—Clinical Results, Pipeline, and Strategic Overview - Minichart

Mar 26, 2026

Mar 26, 2026

Cognition Therapeutics Highlights 2025 Results, Zervimesine Progress - TipRanks

Mar 26, 2026

Mar 26, 2026

Cognition Therapeutics Q4 2025 Earnings Call Transcript - MarketBeat

Mar 26, 2026

Mar 26, 2026

Earnings Call Summary | Cognition Therapeutics(CGTX.US) Q4 2025 Earnings Conference - 富途牛牛

Mar 26, 2026

Mar 26, 2026

Cognition Therapeutics Q4 Earnings Call Highlights - MarketBeat

Mar 26, 2026

Mar 26, 2026

Cognition Therapeutics (NASDAQ:CGTX) Posts Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

Mar 26, 2026

Mar 26, 2026

Earnings call transcript: Cognition Therapeutics Q4 2025 shows reduced losses - Investing.com

Mar 26, 2026

Mar 26, 2026

Cognition Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 26, 2026

Mar 26, 2026

CGTX: Zervimesine advances toward DLB psychosis registration, with strong data and solid cash position - TradingView

Mar 26, 2026

Mar 26, 2026

Earnings call transcript: Cognition Therapeutics Q4 2025 shows reduced losses By Investing.com - Investing.com South Africa

Mar 26, 2026

Mar 26, 2026

CGTX: Zervimesine advances for DLB psychosis with strong data, regulatory focus, and improved 2025 financials - TradingView

Mar 26, 2026

Mar 26, 2026

Cognition Therapeutics posts narrower 2025 loss, eyes DLB trial - Investing.com

Mar 26, 2026

Mar 26, 2026

COGNITION THERAPEUTICS ($CGTX) Releases Q4 2025 Earnings | CGTX Stock News - Quiver Quantitative

Mar 26, 2026

Mar 26, 2026

Cognition Therapeutics 10-K: Net loss $23.5M, EPS $(0.32) - TradingView

Mar 26, 2026

Mar 26, 2026

Zervimesine pipeline and grant backing at Cognition (NASDAQ: CGTX) - Stock Titan

Mar 26, 2026

Mar 26, 2026

Cognition Therapeutics (NASDAQ: CGTX) narrows 2025 loss, funds into Q2 2027 - stocktitan.net

Mar 26, 2026

Mar 26, 2026

Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update - The Manila Times

Mar 26, 2026

Mar 26, 2026

Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical ... - Caledonian Record

Mar 26, 2026

Mar 26, 2026

Earnings Scheduled For March 26, 2026 - Benzinga

Mar 26, 2026

Mar 25, 2026

Cognition Therapeutics (CGTX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Mar 25, 2026

Mar 24, 2026

Cognition Therapeutics Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Mar 24, 2026

Mar 23, 2026

Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results - The Globe and Mail

Mar 23, 2026

Mar 23, 2026

Cognition Therapeutics sets March 26 webcast on 2025 results - Stock Titan

Mar 23, 2026